FDA approvals

bluebird
Pharma

Along with CRISPR nod, FDA approves bluebird's SCD gene therapy

The FDA cleared bluebird's SCD gene therapy Lyfgenia and Vertex/CRISPR's CRISPR-based Casgevy at the same time.
Angus Liu Dec 8, 2023 1:22pm
Jaypirca

Lilly's Jaypirca blazes CLL trail with FDA approval

Dec 4, 2023 4:11am
FDA

FDA clears Pfizer spinout SpringWorks' rare disease drug Ogsiveo

Nov 27, 2023 6:18pm
AZ

AZ's first-in-class breast cancer approval marred by restriction

Nov 17, 2023 11:02am
Asia

Novartis-Legend, Astellas, Ajinomoto—Fierce Pharma Asia

Nov 17, 2023 8:00am
BMS

FDA clears Bristol Myers cancer drug from Turning Point buy

Nov 16, 2023 11:10am